Grayson Paul A.
SEC insider (Form 3/4/5 filer). CIK 0001861554. Director at Skye Bioscience, Inc. (SKYE). 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 31, 2026. Located in SAN DIEGO, CA.
Companies Grayson Paul A. has filed insider reports for
- Skye Bioscience, Inc. (SKYE): Director
Grayson Paul A.
CIK: 0001861554
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Skye Bioscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 31, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
75K shares- - Feb 6, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
35K shares- - Feb 24, 2025SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
135K shares- - Nov 18, 2024SKYE
Skye Bioscience, Inc.
SaleDirect86.2K shares at avg. $4.99$430K - Nov 15, 2024SKYE
Skye Bioscience, Inc.
SaleDirect307 shares at avg. $5.55$2K - Oct 28, 2024SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
70K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 31, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 75,000 | - | - | Direct |
| Feb 6, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 35,000 | - | - | Direct |
| Feb 24, 2025 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 135,000 | - | - | Direct |
| Nov 18, 2024 | SKYE Skye Bioscience, Inc. | Sale | 86,244 | $4.99 | $430,358 | Direct |
| Nov 15, 2024 | SKYE Skye Bioscience, Inc. | Sale | 307 | $5.55 | $1,704 | Direct |
| Oct 28, 2024 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
1-6 of 6 transactions